Boston Scientific BSX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.2B+11.6% | $5.29B+15.9% | $5.07B+20.3% | $5.06B+22.8% | $4.66B+20.9% | ||
| $1.59B+9.4% | $1.61B+9.7% | $1.52B+16.1% | $1.64B+28.9% | $1.45B+20.2% | ||
| $3.61B+12.6% | $3.68B+18.8% | $3.54B+22.3% | $3.42B+20.1% | $3.21B+21.3% | ||
| 69.4%+0.6pp | 69.6%+1.7pp | 69.9%+1.1pp | 67.7%-1.5pp | 68.8%+0.2pp | ||
| $1.78B+11.5% | $1.83B+13.8% | $1.74B+11.5% | $1.72B+18.7% | $1.6B+17.1% | ||
| $3M-70.0% | $16M+300% | -$8M-200% | $83M+8,200% | $10M+233% | ||
| $2.51B+9.8% | $2.85B+17.9% | $2.49B+15.2% | $2.61B+11.8% | $2.29B+16.0% | ||
| $2.51B+9.8% | $2.85B+17.9% | $2.49B+15.2% | $2.61B+11.8% | $2.29B+16.0% | ||
| $1.1B+19.5% | $825M+22.2% | $1.05B+43.0% | $819M+57.5% | $921M+36.4% | ||
| 21.2%+1.4pp | 15.6%+0.8pp | 20.7%+3.3pp | 16.2%+3.6pp | 19.8%+2.2pp | ||
| $90M+9.8% | $90M+12.5% | $87M+10.1% | $90M+16.9% | $82M+18.8% | ||
| $1.16B+44.3% | $700M+19.7% | $939M+40.4% | $941M+124% | $805M+32.4% | ||
| -$176M-232% | $30M+30.4% | $183M-8.5% | $146M+49.0% | $133M+15.7% | ||
| $1.34B+99.3% | $670M+19.2% | $755M+61.3% | $795M+147% | $672M+36.3% | ||
| 25.7%+11.3pp | 12.7%+0.4pp | 14.9%+3.8pp | 15.7%+7.9pp | 14.4%+1.6pp | ||
| $0.90+100% | $0.45+18.4% | $0.51+59.4% | $0.53+141% | $0.45+36.4% | ||
| $0.90+95.7% | $0.46+21.1% | $0.51+59.4% | $0.54+145% | $0.46+35.3% | ||
| 1.5B+0.1% | 1.5B+0.6% | 1.5B+0.5% | 1.5B+0.6% | 1.5B+0.8% | ||
| 1.5B+0.5% | 1.5B+0.6% | 1.5B+0.6% | 1.5B+0.6% | 1.5B+0.6% | ||
| $12M-14.3% | $6M-33.3% | $12M+140% | $14M+55.6% | $14M+40.0% | ||
| $232M+5.9% | $228M+1.3% | $225M+9.8% | $225M+5.6% | $219M+2.3% | ||
| $151M+544% | —— | -$23M-264% | $213M+1,026% | -$34M-1,800% | ||
| $516M+16.5% | $569M+24.0% | $514M+26.3% | $526M+37.3% | $443M+21.0% | ||
| $5.2B+11.6% | $5.29B+15.9% | $5.07B+20.3% | $5.06B+22.8% | $4.66B+20.9% | ||
| $1.45B+16.5% | $1.19B+16.3% | $1.39B+33.8% | $1.16B+39.0% | $1.25B+27.3% | ||
| 27.9%+1.2pp | 22.5%+0.1pp | 27.4%+2.8pp | 22.8%+2.7pp | 26.7%+1.3pp | ||
| $1.1B+19.5% | $825M+22.2% | $1.05B+43.0% | $819M+57.5% | $921M+36.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Boston Scientific's revenue?
- Boston Scientific (BSX) generated $20.6B in revenue over the trailing twelve months, up 17.4% year over year.
- Is Boston Scientific profitable?
- Boston Scientific reported $3.6B in net income over the trailing twelve months, a 17.3% net margin.
- What are Boston Scientific's profit margins?
- Gross margin is 69.2% and operating margin is 18.4%, with a 17.3% net margin.
- What is Boston Scientific's earnings per share?
- Boston Scientific's diluted EPS over the trailing twelve months is $2.39.
- Where does Boston Scientific's income statement data come from?
- Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
